In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2652-2663

  Fukuoka, Takashi ^a   Ohya, Satoshi ^a   Utsui, Yukio ^a   Domon, Haruki ^a   Takenouchi, Takashi ^a   Koga, Tetsufumi ^a   Masuda, Nobuhisa ^a   Kawada, Harumi ^a   Kakuta, Masayo ^a   Kubota, Mikie ^a   Ishii, Chie ^a   Ishii, Chika ^a   Sakagawa, Eiko ^a   Harasaki, Tamako ^a   Hirasawa, Akiko ^a   Abe, Tomomi ^a   Yasuda, Hiroshi ^a   Iwata, Masayuki ^a   Kuwahara, Shogo ^b  

^a DAIICHI SANKYO CO   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM DERIVATIVE; CEFDINIR; CEFDITOREN; CEFPODOXIME; CEFTERAM; DRUG METABOLITE; IMIPENEM; METICILLIN; OFLOXACIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; CITROBACTER FREUNDII; CLOSTRIDIUM PERFRINGENS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MOUSE; NEISSERIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEUS VULGARIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030735199     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2652     Document Type: Article

References (30)

1. Ajiki, Y., T. Koga, S. Ohya, T. Takenouchi, H. Yasuda, K. Watanabe, and K. Ueno. 1991. β-Lactamase produced by a highly β-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections. J. Antimicrob. Chemother. 28:537-546.
2. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
3. Bliss, C. I. 1934. The method of probits. Science 79:38-39.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Caputo, G. M., P. C. Appelbaum, and H. H. Liu. 1993. Infections due to penicillin-resistant pneumococci. Clinical, epidemiologic, and microbiologic features. Arch. Intern. Med. 153:1301-1310.
6. Committee for Revision of MIC Determination Method. 1981. Revisiorn of minimal inhibitory concentration (MIC) determination method. Chemotherapy (Tokyo) 29:76-79.
7. Curtis, N. A. C., M. V. Hayes, A. W. Wyke, and J. B. Ward. 1980. A mutant of Staphylococcus aureus H lacking penicillin-binding protein 4 and transpeptidase activity in vitro. FEMS Microbiol. Lett. 9:263-266.
8. Curtis, N. A. C., and M. V. Hayes. 1981. A mutant of Staphylococcus aureus H deficient in penicillin-binding protein 1 is viable. FEMS Microbiol. Lett. 10:227-229.
9. Fujii-Kuriyama, Y., M. Yamamoto, and S. Sugawara. 1977. Purification and properties of β-lactamase from Proteus morganii. J. Bacteriol. 131:726-734.
10. Georgopapadakou, N. H., B. A. Dix, and Y. R. Mauriz. 1986. Possible physiological functions of penicillin-binding proteins in Staphylococcus aureus. Antimicrob. Agents Chemother. 29:333-336.
11. Hayes, M. V., N. A. C. Curtis, A. W. Wyke, and J. B. Ward. 1981. Decreased affinity of a penicillin-binding protein for β-lactam antibiotics in clinical isolates of Staphylococcus aureus resistant to methicillin. FEMS Microbiol. Lett. 10:119-122.
12. Neu, H. C. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
13. Neu, H. C., A. Novelli, and N.-X. Chin. 1989. In vitro activity and β-lactamase stability of a new carbapenem, SM-7338. Antimicrob. Agents Chemother. 33:1009-1018.
14. Neù, H. C., G. Saha, N.-X. Chin. 1989. Comparative in vitro activity and β-lactamase stability of FK482, a new oral cephalosporin. Antimicrob. Agents Chemother. 33:1795-1800.
15. Neu, H. C., N.-X. Chin, G. Saha, and P. Labthavikul. 1986. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and β-lactamase stability of RS-533, a novel carbapenem. Antimicrob. Agents Chemother. 30:828-834.
16. Neu, H. C., and P. Labthavikul. 1982. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its β-lactamase stability. Antimicrob. Agents Chemother. 21:180-187.
17. Ohya, S., T. Fukuoka, T. Koga, T. Takenouchi, H. Kawada, T. Harasaki, A. Hirasawa, C. Ishii, E. Sakagawa, M. Kubota, H. Yasuda, M. Iwata, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. III. In vivo evaluation of CS-834, abstr. F107, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Okamoto, S., Y. Hamana, M. Inoue, and S. Mitsuhashi. 1987. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral β-lactam antibiotics. Antimicrob. Agents Chemother. 31:1111-1116.
19. Sanders, C. C. 1992. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 14:1089-1099.
20. Spika, J. S., R. R. Facklam, B. D. Plikaytis, M. J. Oxtoby, and the Pneumococcal Surveillance Working Group. 1991. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J. Infect. Dis. 163:1273-1278.
21. Spratt, B. G. 1977. Properties of the penicillin-binding proteins of Escherichia coli K 12. Eur. J. Biochem. 72:341-352.
22. Tajima, M., S. Masuyoshi, M. Inoue, Y. Takenouchi, S. Sugawara, and S. Mitsuhashi. 1981. Purification and properties of β-lactamase from Serratia marcescens. J. Gen. Microbiol. 126:179-184.
23. Tajima, M., Y. Takenouchi, S. Sugawara, M. Inoue, and S. Mitsuhashi. 1980. Purification and properties of chromosomally mediated β-lactamase from Citrobacter freundii GN7391. J. Gen. Microbiol. 121:449-456.
24. Tajima, M., Y. Takenouchi, S. Ohya, and S. Sugawara. 1982. Purification and properties of β-lactamase from Proteus vulgaris. Microbiol. Immunol. 26:531-534.
25. Takenouchi, T., Y. Utsui, S. Ohya, and T. Nishino. 1994. Role of β-lactamase of methicillin-susceptible Staphylococcus aureus in resistance to first-generation oral cephems both in vitro and in vivo. J. Antimicrob. Chemother. 34:909-920.
26. Tamura, A., R. Okamoto, T. Yoshida, H. Yamamoto, S. Kondo, M. Inoue, and S. Mitsuhashi. 1988. In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob. Agents Chemother. 32: 1421-1426.
27. Utsui, Y., M. Inoue, and S. Mitsuhashi. 1987. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob. Agents Chemother. 31:1085-1092.
28. Utsui, Y., T. Takenouchi, N. Masuda, H. Domon, M. Kakuta, C. Ishii, C. Ishii, E. Sakagawa, T. Abe, S. Ohya, H. Yasuda, M. Iwata, and S. Kuwahara. 1996. CS-834, a new oral carbapenem. II. In vitro evaluation of R-95867, the active metabolite of CS-834, abstr. F106, p. 118. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
29. Utsui, Y., and T. Yokota. 1985. Role of an altered penicillin-binding protein in methicillin- and cenhem-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 28:397-403.
30. Waley, S. G. 1974. A spectrophotometric assay of β-lactamase action on penicillins. Biochem. J. 139:780-789.